Viral Vectors Struggle to Penetrate Cystic Fibrosis Sputum
Author Information
Author(s): Hida Kaoru, Lai Samuel K., Suk Jung Soo, Won Sang Y., Boyle Michael P., Hanes Justin
Primary Institution: The Johns Hopkins University
Hypothesis
Can viral vectors used in gene therapy effectively penetrate the sputum of cystic fibrosis patients?
Conclusion
The study found that common viral vectors used in cystic fibrosis gene therapy are significantly hindered by the properties of CF sputum, which limits their effectiveness.
Supporting Evidence
- Adenovirus and AAV5 were slowed by over 3,000 and 12,000-fold in sputum compared to their theoretical speeds in water.
- Only 0.4% of AdV and 2.7% of AAV5 are expected to penetrate a 10 µm thick sputum layer after one hour.
- Muco-inert nanoparticles penetrated sputum at rates only 40-fold reduced compared to in pure water.
Takeaway
This study shows that the thick mucus in cystic fibrosis patients makes it really hard for gene therapy viruses to get through and do their job.
Methodology
The researchers used high resolution multiple particle tracking to measure the diffusion of viral vectors in fresh, undiluted sputum from cystic fibrosis patients.
Limitations
The study primarily focused on two viral vectors and did not explore other potential gene delivery methods.
Participant Demographics
Sputum samples were collected from cystic fibrosis patients.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website